Lin Wu

Title: Lin Wu - Innovator in Cancer Monitoring Technologies

Introduction

Lin Wu is a prominent inventor based in Moraga, California, known for his significant contributions to cancer monitoring technologies. He holds two patents that focus on improved methods for assessing the status of solid-tumor cancers through blood testing. His work has the potential to enhance the accuracy and efficiency of cancer diagnostics.

Latest Patents

Lin Wu's latest patents include innovative methods for EGFR blood monitoring and mutation testing. The EGFR blood monitoring patent involves improved techniques for detecting tumor-associated mutations in a subject's blood, which can provide critical information regarding the status of solid-tumor cancers. Similarly, his mutation testing patent focuses on enhanced methods for assessing the presence of these mutations, further aiding in the diagnosis and treatment of cancer.

Career Highlights

Throughout his career, Lin Wu has worked with notable organizations, including Roche Molecular Systems, Inc. and Aarhus University. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer monitoring.

Collaborations

Lin Wu has collaborated with esteemed colleagues such as Peter Meldgaard and Boe Sorensen, contributing to the advancement of cancer research and diagnostics.

Conclusion

Lin Wu's work in cancer monitoring technologies exemplifies the impact of innovation in the medical field. His patents represent a significant step forward in the fight against cancer, providing new tools for early detection and treatment.